PROSTATE CANCER RECURRENT
Clinical trials for PROSTATE CANCER RECURRENT explained in plain language.
Never miss a new study
Get alerted when new PROSTATE CANCER RECURRENT trials appear
Sign up with your email to follow new studies for PROSTATE CANCER RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for prostate cancer recurrence: precise radiation without major surgery
Disease control Recruiting nowThis study tests a precise radiation treatment (MR-guided high-dose-rate brachytherapy) for men whose prostate cancer has returned in the prostate bed after previous radiotherapy. About 20 participants will receive this targeted therapy to see if it can control the cancer with ac…
Matched conditions: PROSTATE CANCER RECURRENT
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
5-Drug cocktail takes on tough cancers in new trial
Disease control Recruiting nowThis study tests a mix of five oral drugs (hydroxychloroquine, metformin, sirolimus, dasatinib, and nelfinavir) in people with advanced solid tumors or prostate cancer that has come back. The goal is to find the safest dose and see if the combination can stop the cancer from grow…
Matched conditions: PROSTATE CANCER RECURRENT
Phase: PHASE1, PHASE2 • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Engineered donor cells take aim at Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new approach using immune cells from healthy donors, engineered to recognize and attack cancer cells. The target is chosen based on each participant's tumor profile. The trial includes 85 adults with advanced solid tumors that have not responded to standard tre…
Matched conditions: PROSTATE CANCER RECURRENT
Phase: PHASE1, PHASE2 • Sponsor: Essen Biotech • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New hope for men battling hot flashes from prostate cancer treatment
Symptom relief Recruiting nowThis study tests a drug called fezolinetant to see if it can reduce hot flashes in men with prostate cancer who are on hormone therapy (androgen deprivation therapy). About 60 men will take either the drug or a placebo daily for 4 weeks. Researchers will track hot flash frequency…
Matched conditions: PROSTATE CANCER RECURRENT
Phase: PHASE2 • Sponsor: Shehzad Basaria, M.D. • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Lab-Grown Mini-Tumors could predict best prostate cancer therapy
Knowledge-focused Recruiting nowThis study aims to improve treatment for aggressive prostate cancer by growing 3D mini-tumors from patient samples in the lab. Researchers will compare two techniques to see which better predicts how a patient's cancer will respond to radiation or drugs. The goal is to help docto…
Matched conditions: PROSTATE CANCER RECURRENT
Sponsor: Maastricht Radiation Oncology • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Prostate cancer study tracks immune changes during brachytherapy
Knowledge-focused Recruiting nowThis study looks at how the immune system changes in men with prostate cancer who receive brachytherapy (internal radiation). Researchers will collect blood and tissue samples before, during, and after treatment to track immune cells and DNA. The goal is to better understand the …
Matched conditions: PROSTATE CANCER RECURRENT
Sponsor: University of Erlangen-Nürnberg Medical School • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC